Founded in 2019, Leucine operates in Enterprise Tech industry. Initially focused on innovative solutions for the pharma sector, the company now offers comprehensive manufacturing services for pharmace...
Funding stage:
Series A
Last funding:
15/10/2023
Total funding:
$7.00 Mn+
Revenue:
Investors
Employee count:
114
Last 90d
114
Last 90d
Web traffic:
9.63K
9.63K
Last 30d
Last 30d
Glassdoor Rating:
Leucine: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders9
Latest Filing Date30 March 2023- Funding Events9
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Leucine
As of 31 March 2023, Leucine's equity is held by 8 shareholders, with the top three being Vivek Gera, Mustaq Singh Bijral, and Pravega Venture Trust.
Vivek Gera holds the largest stake in Leucine at 32.0% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 58.7% equity in Leucine.
As of 31 March 2023, investors collectively hold 28.1% equity in Leucine.
Leucine's ESOP pool stands at 13.2% of total equity as of 31 March 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links